- About UKABIF
- Join Us
|UKABIF Poster Award 2019|
UKABIF POSTER award 2019
In 2019 UKABIF offered a prize for public engagement. Posters were judged by delegates at the UKABIF Annual Conference which took place on 11th November 2019.
Public engagement is defined as "the involvement of specialists listening to, developing their understanding of, and interacting with, non-specialists".
The winner of the prize was Charlie Flint, Music Therapist from Chroma for his poster: 'Embedding and Sustaining Neurologic Music Therapy on an Acute Stroke Unit to Improve Patient Experience and Outcomes. Can We Do It? Yes We Can, and You Could Too'
1) Charlie Flint, Neurologic Music Therapist
2) Karima Collins, Clinical Lead Speech and Language Therapist
3) Claire Afford, Specialist Speech and Language Therapist
4) Emma Playfair, Senior Occupational Therapist
The acute stroke unit (ASU) at Charing Cross Hospital identified the need for a novel, evidence-based intervention for patients who were unable to engage in ‘traditional’ therapy due to mood or impairment severity. Feasibility in the acute setting and cost effectiveness were primary considerations, along with improving patient experience and psychosocial outcomes. Neurologic Music Therapy (NMT) was the answer.
A 3-phase improvement methodology involved collaboration between Imperial College Healthcare NHS Trust, Chroma Therapies Ltd, and Imperial Health Charity.
Phase 1: 8-week pilot project to introduce 1 day/week of NMT to ASU, and to evaluate impact on patients and feasibility in acute care. Data included: patient-specific clinical outcomes; patient, carer and therapist feedback.
Phase 2: successful grant submission to IHC to fund an increase to 2 days/week over 9 months, allowing us to embed NMT in 1:1 and group sessions, and gather more detailed data to support the case for on-going funding (phase 3).
Initial data suggests improvements in:
- patient experience and wellbeing
- patient outcomes across impairment domains
- staff skills
- philosophy of MDT goal setting
NMT in an ASU is feasible, it does not detract from provision of traditional therapy, there are significant benefits to both patients and staff. It is possible.
Formal analysis of phase 2 data has been completed and submission of bid for permanent funding – to be confirmed in mid-October.